Fusion Antibodies Plc has become an increasingly interesting biotechnology company for investors following the rapid expansion of biologic medicines, antibody-based therapies and pharmaceutical outsourcing worldwide. As pharmaceutical and biotechnology companies continue increasing investment in next-generation therapeutics, specialist contract research organisations with expertise in antibody …
Thalia Therapeutics PLC has steadily gained attention among AIM healthcare investors as interest continues growing in early-stage biotechnology companies developing innovative therapies for diseases with significant unmet clinical needs. While early-stage biotech businesses naturally involve elevated development risk, they also offer substantial long-term upside …
ValiRx PLC has remained one of the more closely followed biotechnology companies on London's AIM market as investors continue searching for innovative healthcare businesses developing next-generation oncology treatments and precision medicine technologies. The biotechnology sector has experienced renewed investor interest as pharmaceutical companies increasingly …
Anpario plc has become one of the more closely followed specialist animal health and nutrition companies listed on the AIM market as global demand for efficient livestock production, sustainable farming practices and premium animal nutrition products continues expanding. Increasing global protein consumption, tighter regulations …
• LSE:CLBX - Cel AI Health plc has become one of today's most closely followed AIM healthcare stocks as investors continue increasing exposure to Artificial Intelligence-driven healthcare businesses.
Shield Therapeutics (LSE:STX) has come into focus after appearing on the list of the UK market’s notable decliners, with the share-price weakness raising questions that traders may now be reassessing.
GSK plc is one of the world's leading biopharmaceutical companies, focused on developing medicines and vaccines across infectious diseases, respiratory conditions, oncology, immunology, and HIV treatments. The company operates in more than 100 countries and continues investing heavily in research and development.
AstraZeneca PLC is one of the world's largest pharmaceutical companies, specialising in oncology, cardiovascular diseases, respiratory treatments, rare diseases, and immunology. The company operates globally and has built one of the industry's most diversified and innovative drug portfolios.
A softer session for PureTech Health (LSE:PRTC) has put the stock in the spotlight, after it ranked among the biggest movers to the downside on a UK trading day.
ConvaTec Group PLC is a global medical technology company specialising in chronic care products across advanced wound care, ostomy care, continence and critical care, and infusion care. The company’s products are used by patients and healthcare providers to manage chronic conditions, supporting quality of …